Oncofid-P-B (paclitaxel-hyaluronic acid) in the intravesical therapy of patients affected by primary or recurrent Ta G1-G2 papillary cancer of the bladder. A phase II marker lesion study

Bassi, P.F. ; Racioppi, M. ; Palermo, G. ; Selli, C. ; Battaglia, M. ; Gontero, P. ; Simeone, C. ; Eisendhardt, A. ; Vom Dorp, F. ; Neisius, A. ; Arjona, M.F. ; Castro Diaz, D. ; Ramirez Backhaus, M. ; Moreno Sierra, J. ; Llorente, C. ; Nohales Taurines, G. ; Giordan, N. ; Marinello, A.

Texto completo disponível